--- title: "Pre-market hot trades in US stocks: Sonder pre-market down 8.28%; Grayscale Ethereum Trust ETF pre-market up 5.56%" type: "News" locale: "en" url: "https://longbridge.com/en/news/261853106.md" description: "Sonder pre-market down 8.28%; Grayscale Ethereum Trust ETF pre-market up 5.56%; FGI Industries pre-market up 57.35%; Beyond Meat pre-market up 56.44%; Rani Therapeutics pre-market up 40.24%" datetime: "2025-10-20T09:58:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/261853106.md) - [en](https://longbridge.com/en/news/261853106.md) - [zh-HK](https://longbridge.com/zh-HK/news/261853106.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Sonder pre-market down 8.28%; Grayscale Ethereum Trust ETF pre-market up 5.56% **Pre-market Hot Trades in US Stocks** Sonder is down 8.28% in pre-market trading. According to recent key news: 1. On October 18, Sonder Holdings is working with Kirkland & Ellis as legal advisors for a potential restructuring. Last month, Sonder announced that its management and board are consulting with financial advisor Moelis & Co. and external lawyers regarding financing and other strategic options. The company also announced the resignation of its Chief Real Estate Officer, who may be involved in the company's potential bidding plans. Sonder's stock price fell 14% on Friday. 2. Sonder reported its second-quarter results on Tuesday, failing to meet market expectations, which led to further declines in its stock price. 3. Sonder did not immediately respond to Seeking Alpha's email request, adding to market uncertainty. Trading is active, with clear capital flows, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Grayscale Ethereum Trust ETF is up 5.56% in pre-market trading. According to recent important news: 1. On October 19, Ethereum's price is targeting $4,500, with classic chart patterns and on-chain MVRV data suggesting potential upward momentum this month. This news has driven the Grayscale Ethereum Trust ETF higher. Source: TradingView 2. On October 19, FundStrat's Tom Lee stated that although the hype around digital asset treasuries is cooling, he remains confident in Ethereum. This confidence may have boosted market sentiment. Source: -tom-lee-says-treasury-hype-fades-but-backs-1-5b-ether-buy/ 3. On October 17, whale accumulation, reduced exchange supply, and improved sentiment suggest that the next bull market phase for Ethereum is approaching. This market dynamic may have driven the ETF's price increase. Source: -whales-bet-417mln-on-a-rebound-will-eth-charts-agree/ Market trading is active, with significant capital inflows, and caution is advised regarding volatility risks. **Top Gainers in Pre-market US Stocks** FGI Industries is up 57.35% in pre-market trading, with no significant recent news. Trading is active, with clear capital flows, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Beyond Meat is up 56.44% in pre-market trading. According to recent important news: 1. On October 16, Beyond Meat announced the lifting of the lock-up restriction on 316,150,176 new shares. This news triggered market expectations for increased liquidity of the company's stock, driving a significant rise in its stock price 2. On October 17th, the market observed a large amount of funds taking a bearish stance on Beyond Meat, possibly due to investors' concerns about the company's future performance, leading to stock price fluctuations. 3. No other significant news recently. The plant-based meat industry is experiencing increased volatility, and risks should be noted. Rani Therapeutics pre-market rose 40.24%. According to recent important news: 1. On October 17th, Rani Therapeutics signed a licensing agreement with Chugai Pharmaceutical in Japan to develop an experimental drug, with a total agreement value potentially exceeding $1 billion. This news drove Rani's stock price up 156.95% in pre-market trading. Data source: Company announcement. 2. On October 17th, Rani Therapeutics announced a private financing plan totaling $60.3 million, expected to be used to advance the development of its RaniPill platform. This news led to a 150.58% increase in stock price in pre-market trading. Data source: Company announcement. 3. On October 17th, the overall sentiment in the biopharmaceutical sector warmed up, and Rani Therapeutics benefited from the spillover effect of the sector, with rapid capital response during the trading session, driving the stock price up. Data source: Market analysis shows high sentiment in the biopharmaceutical sector, with significant capital inflow ### Related Stocks - [SOND.US](https://longbridge.com/en/quote/SOND.US.md) - [ETHE.US](https://longbridge.com/en/quote/ETHE.US.md) - [SONDQ.US](https://longbridge.com/en/quote/SONDQ.US.md) ## Related News & Research - [Aligned Launches $ALIGN, the Native Token of Its Full Ethereum Stack](https://longbridge.com/en/news/296619468.md) - [SEC Opens Comment Period On Cboe 3x Bitcoin And Ethereum ETF Proposal](https://longbridge.com/en/news/296643740.md) - [Metis to Hold AI Bootcamp Livestream on August 19th](https://longbridge.com/en/news/296136416.md) - [EX DeFi Announces AI-Driven Digital Asset Infrastructure Platform Supporting BTC, ETH and XRP](https://longbridge.com/en/news/296110726.md) - [Goldman Sachs Gains Bitcoin, Ethereum ETFs in $2.25B Deal: Could It 'Leapfrog' BlackRock?](https://longbridge.com/en/news/295710704.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**